Health Catalyst Sees Q3 Sales $55.000M-$56.000M vs $62.159M Est

Benzinga Newsdesk www.benzinga.com Positive 86.2%

Neg 0% Neu 0% Pos 86.2%

Health Catalyst (NASDAQ:HCAT) sees Q3 sales of $55.000 million-$56.000 million vs $62.159 million analyst estimate.

Comments

No comments yet. Be the first!